Boron‐Doped AIE Nanomaterials With NIR‐II Emission for FL/MR Dual‐Modality Tumor Imaging
Source abstract
Abstract
ABSTRACT Boron‐doped aggregation‐induced emission (AIE) nanomaterials (B@AIE NPs) were successfully synthesized via a facile one‐pot solvothermal method for dual‐modality fluorescence (FL) and magnetic resonance (MR) imaging. The as‐prepared B@AIE NPs exhibited a uniform core–shell structure, excellent dispersibility, and strong NIR‐II fluorescence emission at 984 nm upon aggregation, attributed to restricted intramolecular motion. Moreover, the boron doping conferred remarkable T 1 ‐weighted MR contrast capability, with a high longitudinal relaxivity (r 1 ) of 6.12 m m − 1 s − 1 . In vitro studies demonstrated excellent biocompatibility and efficient cellular uptake, with preferential localization in lysosomes. In vivo experiments in HeLa tumor‐bearing mice revealed effective tumor accumulation via the enhanced permeability and retention (EPR) effect, enabling high‐contrast NIR‐II fluorescence and MR imaging. These results highlight the great potential of B@AIE NPs as a promising metal‐free nanoprobe for precise tumor diagnosis through FL/MR dual‐modal imaging.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Carbon and Quantum Dots Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomaterials and Stem Cells Suzhou Institute of Biomedical Engineering and Technology Chinese Academy of Science (CAS) Suzhou China
Jinan Guokeyigong Science and Technology Development Co., Ltd Jinan China
Funding
National Key Research and Development Program of China · Natural Science Foundation of Jiangsu Province · Natural Science Foundation of Shandong Province
References (38)
Show source-provided references
1. 10.1038/s44222‐022‐00002‐810.1038/s44222‐022‐00002‐8 ↗
2. 10.1039/D2CS00525E10.1039/D2CS00525E ↗
3. 10.1002/smll.20220644210.1002/smll.202206442 ↗
4. 10.1038/s41551‐022‐00904‐310.1038/s41551‐022‐00904‐3 ↗
5. 10.1002/smtd.20200106610.1002/smtd.202001066 ↗
6. 10.1016/j.addr.2021.03.00810.1016/j.addr.2021.03.008 ↗
7. 10.1002/smll.20230496810.1002/smll.202304968 ↗
8. 10.1016/j.biomaterials.2018.04.01210.1016/j.biomaterials.2018.04.012 ↗
9. 10.1002/adma.20240604710.1002/adma.202406047 ↗
10. 10.1016/j.ccr.2024.21614810.1016/j.ccr.2024.216148 ↗
11. 10.1002/adma.20241316410.1002/adma.202413164 ↗
12. 10.1021/acsnano.3c0392510.1021/acsnano.3c03925 ↗
13. 10.1016/j.cej.2023.14643610.1016/j.cej.2023.146436 ↗
14. 10.1002/adom.20220307510.1002/adom.202203075 ↗
15. 10.1002/anie.20190983010.1002/anie.201909830 ↗
16. 10.1002/advs.20220085010.1002/advs.202200850 ↗
17. 10.1002/anie.20191672910.1002/anie.201916729 ↗
18. 10.1039/C9CS00495E10.1039/C9CS00495E ↗
19. 10.1038/s41467‐020‐15095‐110.1038/s41467‐020‐15095‐1 ↗
20. 10.1039/C9NH00698B10.1039/C9NH00698B ↗
21. 10.1039/D0NR02291H10.1039/D0NR02291H ↗
22. 10.1002/anie.20241720010.1002/anie.202417200 ↗
23. 10.1002/anie.20220712510.1002/anie.202207125 ↗
24. 10.1002/adma.20210608210.1002/adma.202106082 ↗
25. 10.1016/j.partic.2022.06.00110.1016/j.partic.2022.06.001 ↗
26. 10.1039/D2RA01591A10.1039/D2RA01591A ↗
27. 10.1016/j.talanta.2019.03.02210.1016/j.talanta.2019.03.022 ↗
28. 10.1021/acs.nanolett.9b0009910.1021/acs.nanolett.9b00099 ↗
29. 10.1002/pol.2019033310.1002/pol.20190333 ↗
30. 10.1002/anie.20200689010.1002/anie.202006890 ↗
31. 10.1021/acs.ami.9b1987710.1021/acs.ami.9b19877 ↗
32. 10.1021/acs.nanolett.4c0386610.1021/acs.nanolett.4c03866 ↗
33. 10.1016/j.cclet.2021.08.04310.1016/j.cclet.2021.08.043 ↗
34. 10.1039/B908656B10.1039/B908656B ↗
35. 10.1016/j.envres.2020.11059310.1016/j.envres.2020.110593 ↗
36. 10.1016/j.nantod.2020.10090010.1016/j.nantod.2020.100900 ↗
37. 10.1002/ange.20241052210.1002/ange.202410522 ↗
38. 10.1016/j.cis.2023.10300710.1016/j.cis.2023.103007 ↗